TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $91,793,000 | -0.5% | 5,227,376 | -45.0% | 1.21% | -2.3% |
Q2 2021 | $92,247,000 | +12.1% | 9,510,000 | +24.2% | 1.24% | +1.6% |
Q1 2021 | $82,258,000 | +17.0% | 7,659,000 | +60.2% | 1.22% | +13.0% |
Q4 2020 | $70,335,000 | +54.8% | 4,781,448 | +49.6% | 1.08% | +21.4% |
Q3 2020 | $45,429,000 | +120.5% | 3,197,008 | +25.5% | 0.89% | +98.4% |
Q2 2020 | $20,605,000 | – | 2,547,000 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 174,174 | $298,000 | 0.17% |
Matrix Capital Management Company, LP | 2,288,560 | $3,913,000 | 0.13% |
Samsara BioCapital, LLC | 71,619 | $122,000 | 0.12% |
NEA Management Company, LLC | 1,250,000 | $2,138,000 | 0.08% |
Tekla Capital Management LLC | 446,099 | $763,000 | 0.03% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $306,000 | 0.01% |
Artal Group S.A. | 150,000 | $257,000 | 0.01% |
Baker Brothers Advisors | 505,262 | $864,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $34,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 57,055 | $98,000 | 0.00% |